Update on C3 glomerulopathy. (Q40744602)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25326473%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

14 October 2020

Update on C3 glomerulopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25326473%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

5 references

9 October 2019

27 November 2019

13 December 2019

29 May 2020

14 October 2020

1 reference

9 October 2019

1 reference

27 November 2019

1 reference

13 December 2019

complement system proteins

1 reference

14 October 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25326473%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Marieta M Ruseva

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25326473%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Matthew C Pickering

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25326473%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

language of work or name

English

0 references

publication date

17 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25326473%20AND%20SRC:MED&resulttype=core&format=json

Nephrology Dialysis Transplantation

21 February 2020

1 May 2016

1 reference

14 October 2020

5 references

9 October 2019

27 November 2019

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25326473%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

14 October 2020

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25326473%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25326473%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

717-725

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25326473%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 4.0 International

21 February 2020

copyright license

4 references

9 October 2019

27 November 2019

13 December 2019

Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN.

14 October 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Remission of C3 glomerulopathy with rituximab as only immunosuppressive therapy.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Clinical findings, pathology, and outcomes of C3GN after kidney transplantation

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

C3 glomerulopathy: clinicopathologic features and predictors of outcome

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

C3 glomerulopathy: consensus report

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Dense deposit disease and C3 glomerulopathy

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Toward a working definition of C3 glomerulopathy by immunofluorescence

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Soluble CR1 therapy improves complement regulation in C3 glomerulopathy

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Eculizumab and recurrent C3 glomerulonephritis

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Dimerization of complement factor H-related proteins modulates complement activation in vivo

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

A hybrid CFHR3-1 gene causes familial C3 glomerulopathy.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Eculizumab and Refractory Membranoproliferative Glomerulonephritis

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Eculizumab for the Treatment of Dense-Deposit Disease

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Eculizumab in a patient with dense-deposit disease

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Eculizumab for dense deposit disease and C3 glomerulonephritis

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Genome-wide association study identifies susceptibility loci for IgA nephropathy

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Blockade of alternative complement pathway in dense deposit disease

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Pathology after eculizumab in dense deposit disease and C3 GN.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

A novel CFHR5 mutation associated with C3 glomerulonephritis in a Turkish girl

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Complement factor H-related hybrid protein deregulates complement in dense deposit disease

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Providing guidance in the dark: rare renal diseases and the challenge to improve the quality of evidence.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Evolution of immunoglobulin deposition in C3-dominant membranoproliferative glomerulopathy.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848753

Eculizumab in dense-deposit disease after renal transplantation

19 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FNDT%2FGFU317

Eculizumab therapy in a patient with dense-deposit disease associated with partial lipodystropy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25326473

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25326473

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Rituximab fails where eculizumab restores renal function in C3nef-related DDD

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25326473

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/NDT/GFU317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25326473%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25326473%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25326473%20AND%20SRC:MED&resulttype=core&format=json